DOCSLIB.ORG

Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia viruses Article Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia Katendi Changula 1 , Edgar Simulundu 2,3 , Boniface Pongombo Lombe 4,5,6, Eri Nakayama 7 , Hiroko Miyamoto 4, Yuji Takahashi 4, Hirofumi Sawa 2,8,9, Chuma Simukonda 10, Bernard M. Hang’ombe 1 and Ayato Takada 2,4,9,* 1 Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia; [email protected] (K.C.); [email protected] (B.M.H.) 2 Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia; [email protected] (E.S.); [email protected] (H.S.) 3 Macha Research Trust, P.O. Box 630166, Choma 20100, Zambia 4 Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan; [email protected] (B.P.L.); [email protected] (H.M.); [email protected] (Y.T.) 5 Central Veterinary Laboratory of Kinshasa, Kinshasa BP 8842, Democratic Republic of the Congo 6 Faculty of Veterinary Medicine, National Pedagogic University, Kinshasa BP 8815, Democratic Republic of the Congo 7 Department of Virology I, National Institute of Infectious Diseases, Tokyo 162-0052, Japan; [email protected] 8 Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan 9 International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Citation: Changula, K.; Simulundu, Sapporo 001-0020, Japan E.; Lombe, B.P.; Nakayama, E.; 10 Department of National Parks and Wildlife, Chilanga 10101, Zambia; [email protected] Miyamoto, H.; Takahashi, Y.; Sawa, * Correspondence: [email protected]; Tel.: +81-11-706-9502 H.; Simukonda, C.; Hang’ombe, B.M.; Takada, A. Serological Evidence of Abstract: Ebolaviruses and marburgviruses are filoviruses that are known to cause severe hemor- Filovirus Infection in Nonhuman rhagic fever in humans and nonhuman primates (NHPs). While some bat species are suspected Primates in Zambia. Viruses 2021, 13, 1283. https://doi.org/10.3390/ to be natural reservoirs of these filoviruses, wild NHPs often act as intermediate hosts for viral v13071283 transmission to humans. Using an enzyme-linked immunosorbent assay, we screened two NHP species, wild baboons and vervet monkeys captured in Zambia, for their serum IgG antibodies Academic Editors: James Strong and specific to the envelope glycoproteins of filoviruses. From 243 samples tested, 39 NHPs (16%) were David Safronetz found to be seropositive either for ebolaviruses or marburgviruses with endpoint antibody titers ranging from 100 to 25,600. Interestingly, antibodies reactive to Reston virus, which is found only in Received: 19 May 2021 Asia, were detected in both NHP species. There was a significant difference in the seropositivity for Accepted: 25 June 2021 the marburgvirus antigen between the two NHP species, with baboons having a higher positive rate. Published: 30 June 2021 These results suggest that wild NHPs in Zambia might be nonlethally exposed to these filoviruses, and this emphasizes the need for continuous monitoring of filovirus infection in wild animals to Publisher’s Note: MDPI stays neutral better understand the ecology of filoviruses and to assess potential risks of outbreaks in humans in with regard to jurisdictional claims in previously nonendemic countries. published maps and institutional affil- iations. Keywords: Ebola virus; ebolavirus; Marburg virus; marburgvirus; filovirus; nonhuman primate; antibody; seroprevalence; Zambia Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. 1. Introduction This article is an open access article distributed under the terms and Filoviruses, including ebolaviruses and marburgviruses, have a non-segmented negative- conditions of the Creative Commons stranded RNA genome and are phylogenetically divided into six genera: Ebolavirus, Mar- Attribution (CC BY) license (https:// burgvirus, Cuevavirus, Dianlovirus, Striavirus, and Thamnovirus. The genus Marburgvirus creativecommons.org/licenses/by/ has a single species with two known viruses (Marburg virus (MARV) and Ravn virus), 4.0/). Viruses 2021, 13, 1283. https://doi.org/10.3390/v13071283 https://www.mdpi.com/journal/viruses Viruses 2021, 13, x FOR PEER REVIEW 2 of 10 Viruses 2021, 13, 1283 Sudan ebolavirus, Tai Forest ebolavirus, Bundibugyo ebolavirus, Reston ebolavirus, 2and of 10 Bombali ebolavirus, represented by Ebola virus (EBOV), Sudan virus (SUDV), Taï Forest virus (TAFV), Bundibugyo virus (BDBV), Reston virus (RESTV), and Bombali virus, respec- buttively six [1]. distinct Of these species filoviruses, are currently MARV, known EB inOV, the SUDV, genus Ebolavirus TAFV, and: Zaire BDBV ebolavirus are known, Su- to be danhuman-pathogenic ebolavirus, Tai Forest filoviruses ebolavirus that, Bundibugyo cause he ebolavirusmorrhagic, Reston fever, ebolavirus namely ,Marburg and Bombali virus dis- ebolavirusease (MVD), represented and Ebola by Ebolavirus virus disease (EBOV), (EVD) Sudan in humans virus (SUDV), and nonhuman Taï Forest virus primates (TAFV), (NHPs) Bundibugyo[2]. RESTV causes virus (BDBV), disease Reston in NHPs virus and (RESTV), has also and been Bombali found virus, in pigs respectively [3,4]. Although [1]. it is Ofnot these known filoviruses, to cause MARV, disease EBOV, in humans, SUDV, there TAFV, ha andve been BDBV reports are known of seroconversion to be human- in hu- pathogenicmans after filoviruses contact with that RESTV-infected cause hemorrhagic NHPs fever, or namely pigs Marburg[3,4]. virus disease (MVD) and Ebola virus disease (EVD) in humans and nonhuman primates (NHPs) [2]. RESTV NHPs are known to be highly susceptible to filovirus infection. In some of the previ- causes disease in NHPs and has also been found in pigs [3,4]. Although it is not known ous outbreaks of EVD, large die-offs of NHPs have been recorded prior to or during the to cause disease in humans, there have been reports of seroconversion in humans after contactoutbreaks with [5–8]. RESTV-infected In addition, NHPs NHPs or pigs have [3 ,been4]. implicated as a source of human infection in someNHPs outbreaks, are known with to bethe highlyindex cases susceptible having to handled filovirus infected infection. NH InP carcasses some of the [7,9]. The previoussource of outbreaks infection of in EVD, the largefirst die-offsever recorded of NHPs outbreak have been of recorded a filovirus prior disease, to or during MVD, was theAfrican outbreaks green [5 –monkeys8]. In addition, [10]. NHPsAntibodies have been to vari implicatedous filoviruses as a source have of human been detected infection in sev- ineral some NHP outbreaks, species, with both the in indexareas casesof previously having handled reported infected outbreaks NHP carcassesand those [7 that,9]. The had never sourcereported of infectionan outbreak in the [11–16]. first ever recorded outbreak of a filovirus disease, MVD, was AfricanThe green aim monkeys of this study [10]. Antibodies was to investigate to various the filoviruses possible have exposure been detected of NHPs in several to filoviruses NHPin Zambia, species, where both in neither areas of an previously EVD nor reported an MVD outbreaks outbreak and has those ever that been had recorded. never We reported an outbreak [11–16]. screened 243 serum samples collected from NHPs in Zambia for the detection of filovirus- The aim of this study was to investigate the possible exposure of NHPs to filoviruses in specific IgG. There was evidence of previous exposure to filoviruses in these NHP popu- Zambia, where neither an EVD nor an MVD outbreak has ever been recorded. We screened 243lations. serum samples collected from NHPs in Zambia for the detection of filovirus-specific IgG. There was evidence of previous exposure to filoviruses in these NHP populations. 2. Materials and Methods 2.2.1. Materials Animals and and Methods Serum Samples 2.1. Animals and Serum Samples Serum samples were previously obtained from 125 (41 female and 84 male) yellow Serum samples were previously obtained from 125 (41 female and 84 male) yellow baboons (Papio cynocephalus) and 118 (33 female and 85 male) vervet monkeys (Chlorocebus baboons (Papio cynocephalus) and 118 (33 female and 85 male) vervet monkeys (Chlorocebus pygerythruspygerythrus) in) in game game management management areas areas in the in Mfuwethe Mfuwe region region (Eastern (Eastern Province, Province, Zambia) Zambia) andand Livingstone Livingstone (Southern (Southern Province, Province, Zambia) Zambia) (Figure (Figure1) between 1) between 2008 and 2008 2010 and with 2010 the with the permissionpermission (certificate (certificate no. no. 2604) 2604) of of the the Zambia Zambia Wildlife Wildlife Authority, Authority, which which is mandated is mandated by bythe the Zambian Zambian government government to to control control the the larg largee numbers ofof wildwild NHPs NHPs [ 17[17–19].–19]. Serum Serum sam- samplesples were were stored stored at − at80− °80C ◦untilC until they they were were used. used. The The residual residual serum serum samples samples were were used in usedthe present in the present study. study. Tanzania Democratic Republic of the Congo Mfuwe Malawi Angola Zambia Lusaka Mozambique Livingstone Zimbabwe Namibia Botswana FigureFigure 1. 1.Map Map of of Zambia Zambia showing showing the the location location of the of sampling the sampling sites (Mfuwe sites (Mfuwe and Livingstone). and Livingstone). Viruses 2021, 13, 1283
Load more

Recommended publications
  • Ebola Virus Disease
    Outbreaks Chronology: Ebola Virus Disease Known Cases and Outbreaks of Ebola Virus Disease, in Reverse Chronological Order: Reported number (%) of Reported deaths Ebola number of among Year(s) Country subtype human cases cases Situation August- Democratic Ebola virus 66 49 (74%) Outbreak occurred in November 2014 Republic of multiple villages in the Congo the Democratic Republic of the Congo. The outbreak was unrelated to the outbreak of Ebola in West Africa. March 2014- Multiple Ebola virus 28652 11325 Outbreak across Present countries multiple countries in West Africa. Number of patients is constantly evolving due to the ongoing investigation. 32 November 2012- Uganda Sudan virus 6* 3* (50%) Outbreak occurred in January 2013 the Luwero District. CDC assisted the Ministry of Health in the epidemiologic and diagnostic aspects of the outbreak. Testing of samples by CDC's Viral Special Pathogens Branch occurred at UVRI in Entebbe. 31 June-November Democratic Bundibugyo 36* 13* (36.1%) Outbreak occurred in 2012 Republic of virus DRC’s Province the Congo Orientale. Laboratory support was provided through CDC and the Public Health Agency of Canada (PHAC)’s field laboratory in Isiro, as well as through the CDC/UVRI lab in Uganda. The outbreak in DRC had no epidemiologic link to the near contemporaneous Ebola outbreak in the Kibaale district of Uganda. 31 June-October Uganda Sudan virus 11* 4* (36.4%) Outbreak occurred in 2012 the Kibaale District of Uganda. Laboratory tests of blood samples were conducted by the UVRI and the CDC. 31 May 2011 Uganda Sudan virus 1 1 (100%) The Uganda Ministry of Health informed the public a patient with suspected Ebola Hemorrhagic fever died on May 6, 2011 in the Luwero district, Uganda.
    [Show full text]
  • Replication of Marburg Virus in Human Endothelial Cells a Possible Mechanism for the Development of Viral Hemorrhagic Disease
    Replication of Marburg Virus in Human Endothelial Cells A Possible Mechanism for the Development of Viral Hemorrhagic Disease Hans-Joachim Schnittler,$ Friederike Mahner, * Detlev Drenckhahn, * Hans-Dieter Klenk, * and Heinz Feldmann * *Institut fir Virologie, Philipps-Universitdt Marburg, 3550 Marburg, Germany; tInstitutftirAnatomie, Universitdt Wiirzburg, 8700 Wiirzburg, Germany Abstract Rhabdoviridae, within the new proposed order Mononegavi- Marburg and Ebola virus, members of the family Filoviridae, rales (10). Virions are composed of a helical nucleocapsid cause a severe hemorrhagic disease in humans and primates. surrounded by a lipid envelope. The genome is nonsegmented, The disease is characterized as a pantropic virus infection often of negative sense, and 19 kb in length (3, 11, 12). Virion parti- resulting in a fulminating shock associated with hemorrhage, cles contain at least seven structural proteins (8, 13-16). and death. All known histological and pathophysiological pa- Filovirus infections have several pathological features in rameters of the disease are not sufficient to explain the devas- common with other severe viral hemorrhagic fevers such as tating symptoms. Previous studies suggested a nonspecific de- Lassa fever, hemorrhagic fever with renal syndrome, and struction of the endothelium as a possible mechanism. Con- Dengue hemorrhagic fever (5). Among these viruses, filovi- cerning the important regulatory functions of the endothelium ruses cause the highest case-fatality rates ( - 35% for MBG [61 (blood pressure, antithrombogenicity, homeostasis), we exam- and up to 90% for EBO, subtype Zaire [17]) and the most ined Marburg virus replication in primary cultures of human severe hemorrhagic manifestations. The pathophysiologic endothelial cells and organ cultures of human umbilical cord events that make filovirus infections of humans so devastating veins.
    [Show full text]
  • Comparison and Evaluation of Real-Time Taqman PCR for Detection and Quantification of Ebolavirus
    viruses Article Comparison and Evaluation of Real-Time Taqman PCR for Detection and Quantification of Ebolavirus Yi Huang 1,* , Shuqi Xiao 2 and Zhiming Yuan 1,* 1 National Biosafety Laboratory, Chinese Academy of Sciences, Wuhan 430020, China 2 Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430020, China; [email protected] * Correspondence: [email protected] (Y.H.); [email protected] (Z.Y.) Abstract: Given that ebolavirus causes severe and frequently lethal disease, its rapid and accurate detection using available and validated methods is essential for controlling infection. Real-time reverse-transcription PCR (RT-PCR) has proven to be an invaluable tool for ebolaviruses diagnostics. Many assays with different targets have been developed, but they have not been externally compared or validated, and limits of detection are not uniformly reported. Here we compared and evaluated the sensitivity, reproducibility and specificity of 23 in-house assays under the same conditions. Our results showed that these assays were highly gene- and species- specific when evaluated using in vitro RNA transcripts and viral RNA, and the potential limits of detection were uniformly reported 2 6 ranging from 10 to 10 in vitro synthesized RNA transcripts copies perµL and 1–100 TCID50/mL. The comparison of these assays indicated that those targeting the more conservative NP gene could be the better option for EVD case definition and quantitative measurement because of its higher sensitivity for the same species. Our analysis could contribute to the standardization of ebolavirus detection and quantification assays, which can offer a better understanding of the meaning of results across laboratories and time points, as well as make them easy to implement, especially under outbreak conditions.
    [Show full text]
  • Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
    Emerging Infectious Diseases. Volume 20, Number 10—October 2014 CDC EID journal Ahead of Print / In Press Research Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease Anita K. McElroy , Bobbie R. Erickson, Timothy D. Flietstra, Pierre E. Rollin, Stuart T. Nichol, Jonathan S. Towner, and Christina F. Spiropoulou Author affiliations: Emory University, Atlanta, Georgia, USA (A.K. McElroy); Centers for Disease Control and Prevention, Atlanta (A.K. McElroy, B.R. Erickson, T.D. Flietstra, P.E. Rollin, S.T. Nichol, J.S. Towner, C.F. Spiropoulou) Suggested citation for this article Abstract Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates. Historically, children have been less affected than adults. The 2000–2001 Sudan virus–associated EVD outbreak in the Gulu district of Uganda resulted in 55 pediatric and 161 adult laboratory-confirmed cases. We used a series of multiplex assays to measure the concentrations of 55 serum analytes in specimens from patients from that outbreak to identify biomarkers specific to pediatric disease. Pediatric patients who survived had higher levels of the chemokine regulated on activation, normal T-cell expressed and secreted marker and lower levels of plasminogen activator inhibitor 1, soluble intracellular adhesion molecule, and soluble vascular cell adhesion molecule than did pediatric patients who died. Adult patients had similar levels of these analytes regardless of outcome. Our findings suggest that children with EVD may benefit from different treatment regimens than those for adults. Outbreaks of Ebola virus disease (EVD) occur sporadically in sub-Saharan Africa and are associated with exceptionally high case-fatality rates (CFRs).
    [Show full text]
  • To Ebola Reston
    WHO/HSE/EPR/2009.2 WHO experts consultation on Ebola Reston pathogenicity in humans Geneva, Switzerland 1 April 2009 EPIDEMIC AND PANDEMIC ALERT AND RESPONSE WHO experts consultation on Ebola Reston pathogenicity in humans Geneva, Switzerland 1 April 2009 © World Health Organization 2009 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distin- guished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. This publication contains the collective views of an international group of experts and does not necessarily represent the decisions or the policies of the World Health Organization.
    [Show full text]
  • How Severe and Prevalent Are Ebola and Marburg Viruses?
    Nyakarahuka et al. BMC Infectious Diseases (2016) 16:708 DOI 10.1186/s12879-016-2045-6 RESEARCHARTICLE Open Access How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence Luke Nyakarahuka1,2,5* , Clovice Kankya2, Randi Krontveit3, Benjamin Mayer4, Frank N. Mwiine2, Julius Lutwama5 and Eystein Skjerve1 Abstract Background: Ebola and Marburg virus diseases are said to occur at a low prevalence, but are very severe diseases with high lethalities. The fatality rates reported in different outbreaks ranged from 24–100%. In addition, sero-surveys conducted have shown different seropositivity for both Ebola and Marburg viruses. We aimed to use a meta-analysis approach to estimate the case fatality and seroprevalence rates of these filoviruses, providing vital information for epidemic response and preparedness in countries affected by these diseases. Methods: Published literature was retrieved through a search of databases. Articles were included if they reported number of deaths, cases, and seropositivity. We further cross-referenced with ministries of health, WHO and CDC databases. The effect size was proportion represented by case fatality rate (CFR) and seroprevalence. Analysis was done using the metaprop command in STATA. Results: The weighted average CFR of Ebola virus disease was estimated to be 65.0% [95% CI (54.0–76.0%), I2 = 97.98%] whereas that of Marburg virus disease was 53.8% (26.5–80.0%, I2 = 88.6%). The overall seroprevalence of Ebola virus was 8.0% (5.0%–11.0%, I2 = 98.7%), whereas that for Marburg virus was 1.2% (0.5–2.0%, I2 = 94.8%).
    [Show full text]
  • Development of an Antibody Cocktail for Treatment of Sudan Virus Infection
    Development of an antibody cocktail for treatment of Sudan virus infection Andrew S. Herberta,b, Jeffery W. Froudea,1, Ramon A. Ortiza, Ana I. Kuehnea, Danielle E. Doroskya, Russell R. Bakkena, Samantha E. Zaka,b, Nicole M. Josleyna,b, Konstantin Musiychukc, R. Mark Jonesc, Brian Greenc, Stephen J. Streatfieldc, Anna Z. Wecd,2, Natasha Bohorovae, Ognian Bohorove, Do H. Kime, Michael H. Paulye, Jesus Velascoe, Kevin J. Whaleye, Spencer W. Stoniera,b,3, Zachary A. Bornholdte, Kartik Chandrand, Larry Zeitline, Darryl Sampeyf, Vidadi Yusibovc,4, and John M. Dyea,5 aVirology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702; bThe Geneva Foundation, Tacoma, WA 98402; cFraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711; dDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461; eMapp Biopharmaceutical, Inc., San Diego, CA 92121; and fBioFactura, Inc., Frederick, MD 21701 Edited by Y. Kawaoka, University of Wisconsin–Madison/University of Tokyo, Madison, WI, and approved December 30, 2019 (received for review August 28, 2019) Antibody-based therapies are a promising treatment option for antibody-based immunotherapies. Subsequently, several indepen- managing ebolavirus infections. Several Ebola virus (EBOV)-specific dent groups reported the postexposure efficacy of monoclonal and, more recently, pan-ebolavirus antibody cocktails have been antibody (mAb)-based immunotherapies against EVD in ma- described. Here, we report the development and assessment of a caques when administered as mixtures of two or more mAbs (14–17). Sudan virus (SUDV)-specific antibody cocktail. We produced a panel These landmark studies demonstrated that combination mAb- of SUDV glycoprotein (GP)-specific human chimeric monoclonal based immunotherapies are a viable treatment option for EVD antibodies (mAbs) using both plant and mammalian expression and spurred therapeutic antibody development for filoviruses.
    [Show full text]
  • Understanding Ebola
    Understanding Ebola With the arrival of Ebola in the United States, it's very easy to develop fears that the outbreak that has occurred in Africa will suddenly take shape in your state and local community. It's important to remember that unless you come in direct contact with someone who is infected with the disease, you and your family will remain safe. State and government agencies have been making preparations to address isolated cases of infection and stop the spread of the disease as soon as it has been positively identified. Every day, the Centers of Disease Control and Prevention (CDC) is monitoring developments, testing for suspected cases and safeguarding our lives with updates on events and the distribution of educational resources. Learning more about Ebola and understanding how it's contracted and spread will help you put aside irrational concerns and control any fears you might have about Ebola severely impacting your life. Use the resources below to help keep yourself calm and focused during this unfortunate time. Ebola Hemorrhagic Fever Ebola hemorrhagic fever (Ebola HF) is one of numerous Viral Hemorrhagic Fevers. It is a severe, often fatal disease in humans and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Ebola HF is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. When infection occurs, symptoms usually begin abruptly. The first Ebolavirus species was discovered in 1976 in what is now the Democratic Republic of the Congo near the Ebola River. Since then, outbreaks have appeared sporadically. There are five identified subspecies of Ebolavirus.
    [Show full text]
  • Zika: the Emerging Epidemic
    Contents 1 : T H E DOENÇA MISTERIOSA 2 : T H E O R I G I N S O F T H E V I R U S 3 : O N T H E M O V E 4 : T H E W O R L D H E A R S 5 : M Y F I R S T B R U S H 6 : FA S T A N D F U R I O U S 7 : S E X U A L T R A N S M I S S I O N 8 : N E W Y O R K ’ S F I R S T C A S E 9 : T H E R U M O R S 10: T H E P R O O F 11: D E L AY I N G P R E G N A N C Y 12: T H E F U T U R E 13: Q U E S T I O N S A N D A N S W E R S N O T E S Estimated range of Aedes albopictus and Aedes aegypti in the United States, 2016. Redrawn from a map from the Centers for Disease Control and Prevention. Countries, territories, and areas showing the distribution of Zika virus, 2013–2016. Redrawn from map printed in WHO, “Situation Report: Zika Virus, Microcephaly, and Guillain-Barré Syndrome,” May 26, 2016, p. 4, http://www.who.int/emergencies/zika-virus/situation- report/en/. © 2016 by World Health Organization. ZIKA 1 The Doença Misteriosa I N A U G U S T 2 0 1 5 , something strange began happening in the maternity wards of Recife, a seaside city perched on the northeastern tip of Brazil where it juts out into the Atlantic.
    [Show full text]
  • Taï Forest Virus Does Not Cause Lethal Disease in Ferrets
    microorganisms Article Taï Forest Virus Does Not Cause Lethal Disease in Ferrets Zachary Schiffman 1,2,† , Feihu Yan 3,†, Shihua He 2, Kevin Tierney 2, Wenjun Zhu 2 , Karla Emeterio 1,2, Huajun Zhang 1, Logan Banadyga 2,* and Xiangguo Qiu 2 1 Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; [email protected] (Z.S.); [email protected] (K.E.); [email protected] (H.Z.) 2 Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; [email protected] (S.H.); [email protected] (K.T.); [email protected] (W.Z.); [email protected] (X.Q.) 3 Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130122, China; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Filoviruses are zoonotic, negative-sense RNA viruses, most of which are capable of causing severe disease in humans and nonhuman primates, often with high case fatality rates. Among these viruses, those belonging to the Ebolavirus genus—particularly Ebola virus, Sudan virus, and Bundibugyo virus—represent some of the most pathogenic to humans. Taï Forest virus (TAFV) is thought to be among the least pathogenic ebolaviruses; however, only a single non-fatal case has been documented in humans, in 1994. With the recent success of the ferret as a lethal model for a number of ebolaviruses, we set out to evaluate its suitability as a model for TAFV. Our results demonstrate that, unlike other ebolaviruses, TAFV infection in ferrets does not result in lethal disease.
    [Show full text]
  • Ebolavirus an Animals
    Ebolavirus and Animals Our knowledge to date and how animal health can support the public health emergency Ebolavirus and Animals – Our knowledge to date and how animal health can support the public health emergency • 29 May 2018 Speakers • Lee Myers • Cyprien Felix Biaou Manager a.I. Emergency Management Livestock Development Officer, FAO Centre for Animal Health (EMC-AH) sub-regional Office for Central Africa Coordinator of FAO’s Ebola Incident (FAO-SFC) Coordination Group (ICG) • Claudia Pittiglio • Sophie von Dobschuetz Ecologist Global Surveillance coordinator (EPT-2) FAO Global Early Warning System (FAO- Emergency Prevention system for GLEWS) and Emerging Pandemic Threats transboundary Animal Diseases Programme Phase 2 (EPT-2) (EMPRES-AH) Ebolavirus and Animals – Our knowledge to date and how animal health can support the public health emergency • 29 May 2018 Webinar Content – Ebola and Animals • Presentation of FAO’s activities – Global level (Lee MYERS) – Regional and country levels (Cyprien BIAOU) • Susceptibility of animal species – Wildlife (Claudia PITTIGLIO) – Domestic (Sophie VON DOBSCHUETZ) • Availability of diagnostic tests for animal samples (Sophie VON DOBSCHUETZ) • What AH agencies and partners are doing (Sophie VON DOBSCHUETZ) Ebolavirus and Animals – Our knowledge to date and how animal health can support the public health emergency • 29 May 2018 3 Context of this webinar: <Phylogeny of the family Filoviridae ZEBOV Current outbreak in the Democratic Republic of the Congo (DRC) © Basicmedical Key Ebolavirus and Animals – Our knowledge to date and how animal health can support the public health emergency • 29 May 2018 FAO Ebola Incident Coordination Group (ICG) • In the spirit of One Health, FAO is supporting the efforts of the public health sector in response to the EVD outbreak in the Democratic Republic of the Congo.
    [Show full text]
  • Temporal and Spatial Limitations in Global Surveillance for Bat Filoviruses and Henipaviruses: Online Appendix Daniel J. Becker
    Temporal and spatial limitations in global surveillance for bat filoviruses and henipaviruses: Online Appendix Daniel J. Becker, Daniel E. Crowley, Alex D. Washburne, Raina K. Plowright S1. Systematic search S2. Full reference list S3. Bat phylogeny S4. Post-hoc sampling design analysis S1. Systematic search Figure S1. The data collection and inclusion process for studies of wild bat filovirus and henipavirus prevalence and seroprevalence (PRISMA diagram). Searches used the following string: (bat* OR Chiroptera*) AND (filovirus OR henipavirus OR "Hendra virus" OR "Nipah virus" OR "Ebola virus" OR "Marburg virus" OR ebolavirus OR marburgvirus). Searches were run during October 2017. Publications were excluded if they did not assess filovirus or henipavirus prevalence or seroprevalence in wild bats or were in languages other than English. Records identified with Web of Science, CAB Abstracts, and PubMed (n = 1275) Identification Records after duplicates removed (n = 995) Screening Records screened Records excluded (n = 995) (n = 679) Full-text articles excluded for Full-text articles irrelevance, bats in assessed for eligibility captivity, other bat (n = 316) virus, not filovirus or henipavirus prevalence or Eligibility seroprevalence, not virus in bats (n = 260) Studies included in qualitative synthesis (n = 56) Studies included in Included quantitative synthesis (n = 56; n = 48 for the phylogenetic meta- analysis) S2. Full reference list 1. Amman, Brian R., et al. "Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection." PLoS Pathogens 8.10 (2012): e1002877. 2. de Araujo, Jansen, et al. "Antibodies against Henipa-like viruses in Brazilian bats." Vector- Borne and Zoonotic Diseases 17.4 (2017): 271-274.
    [Show full text]